Ncoa5+/− male mice developed glucose intolerance, hepatic steatosis and hepatocellular carcinoma (HCC), which can be partially reversed by heterozygous deletion of Il-6 gene21,22. This evidence concerns the gene NCOA5 and hepatocellular carcinoma.